Cladribine Tablets After Treatment With Natalizumab (CLADRINA)
Clinical trial NCT04178005 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04178005
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-19
- Primary completion
- 2026-08-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.